Subantimicrobial doses: Periostat promising for rosacea in phase II study.(Rx): An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on April 15, 2004. The length of the article is 671 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Subantimicrobial doses: Periostat promising for rosacea in phase II study.(Rx)
Author: Doug Brunk
Publication:Internal Medicine News (Magazine/Journal)
Date: April 15, 2004
Publisher: International Medical News Group
Volume: 37 Issue: 8 Page: 64(2)

Distributed by Thomson Gale